Efficacy of Medication in Adults With Friedreich Ataxia
The purpose of this study is to evaluate the efficacy of a study drug on arms and hands motor function and manual dexterity. It is also to evaluate the drug on various neurological functions, safety, and tolerability.
- The study involves approximately 6 visits over 3 months
- Participants will take a study medication or a placebo
- Visits will include questionnaires, an electrocardiogram (ECG), medical exams, blood and urine tests, movement tests
- 18-55 years old
- Diagnosed with Freidreich's Ataxia
- BMI between 16 and 40
KeywordsFriedreich's ataxia, Ataxia, Friedreich ataxia, Spinocerebellar degeneration, Central nervous system
Principal InvestigatorS.H. Subramony, MD
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.